| __timestamp | Sarepta Therapeutics, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9757000 | 28203205 |
| Thursday, January 1, 2015 | 1253000 | 99892000 |
| Friday, January 1, 2016 | 5421000 | 133591000 |
| Sunday, January 1, 2017 | 154584000 | 154937000 |
| Monday, January 1, 2018 | 301034000 | 164246000 |
| Tuesday, January 1, 2019 | 380833000 | 175338000 |
| Wednesday, January 1, 2020 | 540099000 | 198321000 |
| Friday, January 1, 2021 | 701887000 | 227490000 |
| Saturday, January 1, 2022 | 933013000 | 212018000 |
| Sunday, January 1, 2023 | 1243336000 | 145238000 |
Unleashing insights
In the competitive landscape of biotechnology, Sarepta Therapeutics, Inc. and Travere Therapeutics, Inc. have showcased contrasting revenue trajectories over the past decade. Starting in 2014, Sarepta's revenue surged by an impressive 12,600%, reaching approximately $1.24 billion by 2023. This growth underscores Sarepta's strategic advancements and market penetration. In contrast, Travere's revenue, while more stable, grew by about 415% over the same period, peaking at around $227 million in 2021 before a slight decline. This divergence highlights the dynamic nature of the biotech sector, where innovation and strategic positioning can lead to significant financial outcomes. As we look to the future, these trends offer valuable insights into the evolving strategies of biotech firms and their impact on financial performance.
Eli Lilly and Company or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Sarepta Therapeutics, Inc.
Breaking Down Revenue Trends: argenx SE vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. and Pharming Group N.V.: A Comprehensive Revenue Analysis
Sarepta Therapeutics, Inc. and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Sarepta Therapeutics, Inc. or ACADIA Pharmaceuticals Inc.?
Sarepta Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd.: A Comprehensive Revenue Analysis
Halozyme Therapeutics, Inc. and Travere Therapeutics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Pharming Group N.V. vs Travere Therapeutics, Inc.
Bausch Health Companies Inc. vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared
Revenue Showdown: Taro Pharmaceutical Industries Ltd. vs Travere Therapeutics, Inc.
Revenue Insights: Travere Therapeutics, Inc. and Novavax, Inc. Performance Compared